Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Observational study mortality in treated primary aldosteronism: the German Conn's registry.

Reincke M, Fischer E, Gerum S, Merkle K, Schulz S, Pallauf A, Quinkler M, Hanslik G, Lang K, Hahner S, Allolio B, Meisinger C, Holle R, Beuschlein F, Bidlingmaier M, Endres S; German Conn's Registry-Else Kröner-Fresenius-Hyperaldosteronism Registry.

Hypertension. 2012 Sep;60(3):618-24. doi: 10.1161/HYPERTENSIONAHA.112.197111. Epub 2012 Jul 23.

2.

Is primary aldosteronism associated with diabetes mellitus? Results of the German Conn's Registry.

Reincke M, Meisinger C, Holle R, Quinkler M, Hahner S, Beuschlein F, Bidlingmaier M, Seissler J, Endres S; Participants of the German Conn's Registry.

Horm Metab Res. 2010 Jun;42(6):435-9. doi: 10.1055/s-0029-1246189. Epub 2010 Jan 29.

PMID:
20119885
3.

Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn's Registry.

Born-Frontsberg E, Reincke M, Rump LC, Hahner S, Diederich S, Lorenz R, Allolio B, Seufert J, Schirpenbach C, Beuschlein F, Bidlingmaier M, Endres S, Quinkler M; Participants of the German Conn's Registry.

J Clin Endocrinol Metab. 2009 Apr;94(4):1125-30. doi: 10.1210/jc.2008-2116. Epub 2009 Feb 3.

PMID:
19190103
4.

Increased prevalence of diabetes mellitus and the metabolic syndrome in patients with primary aldosteronism of the German Conn's Registry.

Hanslik G, Wallaschofski H, Dietz A, Riester A, Reincke M, Allolio B, Lang K, Quack I, Rump LC, Willenberg HS, Beuschlein F, Quinkler M, Hannemann A; participants of the German Conn's Registry.

Eur J Endocrinol. 2015 Nov;173(5):665-75. doi: 10.1530/EJE-15-0450. Epub 2015 Aug 26.

5.

Risk factors associated with a low glomerular filtration rate in primary aldosteronism.

Reincke M, Rump LC, Quinkler M, Hahner S, Diederich S, Lorenz R, Seufert J, Schirpenbach C, Beuschlein F, Bidlingmaier M, Meisinger C, Holle R, Endres S; Participants of German Conn's Registry.

J Clin Endocrinol Metab. 2009 Mar;94(3):869-75. doi: 10.1210/jc.2008-1851. Epub 2008 Dec 30.

PMID:
19116235
6.

The diagnosis and treatment of primary hyperaldosteronism in Germany: results on 555 patients from the German Conn Registry.

Schirpenbach C, Segmiller F, Diederich S, Hahner S, Lorenz R, Rump LC, Seufert J, Quinkler M, Bidlingmaier M, Beuschlein F, Endres S, Reincke M.

Dtsch Arztebl Int. 2009 May;106(18):305-11. doi: 10.3238/arztebl.2009.0305. Epub 2009 May 1.

7.

Assay characteristics influence the aldosterone to renin ratio as a screening tool for primary aldosteronism: results of the German Conn's registry.

Fischer E, Reuschl S, Quinkler M, Rump LC, Hahner S, Bidlingmaier M, Reincke M; Participants of the German Conn's Registry - Else Kröner-Fresenius-Hyperaldosteronism Registry.

Horm Metab Res. 2013 Jul;45(7):526-31. doi: 10.1055/s-0033-1343448. Epub 2013 Apr 23.

PMID:
23613013
8.

Age below 40 or a recently proposed clinical prediction score cannot bypass adrenal venous sampling in primary aldosteronism.

Riester A, Fischer E, Degenhart C, Reiser MF, Bidlingmaier M, Beuschlein F, Reincke M, Quinkler M.

J Clin Endocrinol Metab. 2014 Jun;99(6):E1035-9. doi: 10.1210/jc.2013-3789. Epub 2014 Mar 6.

PMID:
24601689
9.

SFE/SFHTA/AFCE consensus on primary aldosteronism, part 1: Epidemiology of PA, who should be screened for sporadic PA?

Baguet JP, Steichen O, Mounier-Véhier C, Gosse P.

Ann Endocrinol (Paris). 2016 Jul;77(3):187-91. doi: 10.1016/j.ando.2016.01.006. Epub 2016 Apr 15.

PMID:
27087531
10.

Low testosterone concentrations in men contribute to the gender gap in cardiovascular morbidity and mortality.

Haring R, John U, Völzke H, Nauck M, Dörr M, Felix SB, Wallaschofski H.

Gend Med. 2012 Dec;9(6):557-68. doi: 10.1016/j.genm.2012.10.007. Epub 2012 Nov 20.

PMID:
23182129
11.

Excess Mortality among Persons with Type 2 Diabetes.

Tancredi M, Rosengren A, Svensson AM, Kosiborod M, Pivodic A, Gudbjörnsdottir S, Wedel H, Clements M, Dahlqvist S, Lind M.

N Engl J Med. 2015 Oct 29;373(18):1720-32. doi: 10.1056/NEJMoa1504347.

12.

Evidence of primary aldosteronism in a predominantly female cohort of normotensive individuals: a very high odds ratio for progression into arterial hypertension.

Markou A, Pappa T, Kaltsas G, Gouli A, Mitsakis K, Tsounas P, Prevoli A, Tsiavos V, Papanastasiou L, Zografos G, Chrousos GP, Piaditis GP.

J Clin Endocrinol Metab. 2013 Apr;98(4):1409-16. doi: 10.1210/jc.2012-3353. Epub 2013 Mar 7.

PMID:
23471976
13.

Quality of life in patients with primary aldosteronism: gender differences in untreated and long-term treated patients and associations with treatment and aldosterone.

Künzel HE, Apostolopoulou K, Pallauf A, Gerum S, Merkle K, Schulz S, Fischer E, Brand V, Bidlingmaier M, Endres S, Beuschlein F, Reincke M.

J Psychiatr Res. 2012 Dec;46(12):1650-4. doi: 10.1016/j.jpsychires.2012.08.025. Epub 2012 Sep 25.

PMID:
23017810
14.

Cardiovascular complications in patients with primary aldosteronism.

Nishimura M, Uzu T, Fujii T, Kuroda S, Nakamura S, Inenaga T, Kimura G.

Am J Kidney Dis. 1999 Feb;33(2):261-6.

PMID:
10023636
15.

Clinical Case of the Month: PERSISTENT HYPERTENSION IN A YOUNG WOMAN: A CLASSIC PRESENTATION OF CONN'S SYNDROME.

Yandle G, Vonderhaar DJ, Thayalakulasingam T, Zieske A, Smith D, Engel LS, Richards R, Lopez FA.

J La State Med Soc. 2016 Jan-Feb;168(1):23-6. Epub 2016 Feb 15.

PMID:
26986864
16.

[Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].

Szücs N, Gláz E, Varga I, Tóth M, Kiss R, Patócs A, Jakab C, Perner F, Járay J, Horányi J, Dabasi G, Molnár F, Major L, Füto L, Rácz K, Tulassay Z.

Orv Hetil. 2006 Jan 15;147(2):51-9. Hungarian.

PMID:
16509213
17.

[Relationship between metabolic diseases and all-cause and cardiovascular death in an elderly male population during a 15-year follow-up].

Sun B, Shao Y, Li J, Tian H, Li C.

Zhonghua Yi Xue Za Zhi. 2014 Apr 1;94(12):913-8. Chinese.

PMID:
24854911
18.

The cardiovascular markers copeptin and high-sensitive C-reactive protein decrease following specific therapy for primary aldosteronism.

Remde H, Dietz A, Emeny R, Riester A, Peters A, de Las Heras Gala T, Then C, Seissler J, Beuschlein F, Reincke M, Quinkler M.

J Hypertens. 2016 Oct;34(10):2066-73. doi: 10.1097/HJH.0000000000001041.

PMID:
27442789
19.

Clinical and biochemical characteristics of normotensive patients with primary aldosteronism: a comparison with hypertensive cases.

Médeau V, Moreau F, Trinquart L, Clemessy M, Wémeau JL, Vantyghem MC, Plouin PF, Reznik Y.

Clin Endocrinol (Oxf). 2008 Jul;69(1):20-8. doi: 10.1111/j.1365-2265.2008.03213.x. Epub 2008 Jul 1.

PMID:
18284637
20.

The relationship of vitamin D status to risk of cardiovascular disease and mortality.

Skaaby T.

Dan Med J. 2015 Feb;62(2). pii: B5008. Review.

PMID:
25634511

Supplemental Content

Support Center